EGFR and neoplasm: Furthermore, in melanoma, β2-AR activation by (R, R')-MNF enhances eEF2 phosphorylation, leading to reduced expression of tumor regulators such as EGFR, cyclin A, and MMP-9, thereby suppressing tumor growth and progression [48].